FDA Calls For Removal Of Opiod Painkiller From The Market
The FDA, U.S. Food & Drug Association, has requested that Endo Pharmaceuticals remove their reformulated Opana ER (oxymorphone hydrochloride) opioid pain medication from the market. This is the first time the FDA has ever asked for removal of a previously approved medication. Visit streaming.thesource.com for more information Opana ER was first approved for use in […]
